Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals Inc.
WKN: A1T7BJ / Symbol: ENTA / Name: Enanta / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
12,50 €
-
Enanta Pharmaceuticals (NASDAQ:ENTA) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat
Enanta Pharmaceuticals (NASDAQ:ENTA) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat
Enanta Pharmaceuticals (NASDAQ:ENTA) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $17.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat
Neueste Beiträge
Deutsche_Bank_Aktien in Sutro Biopharma Inc diskutieren